Edesa Biotech, Inc. (EDSA) stock
EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.96+0.07 (+3.70%)
Close on Nov 17, 2026Market cap $18.90MP/E –Yield –
Edesa Biotech cash
Cash and short-term investments held at the end of each period.
Edesa Biotech's cash was $10.30M at Jun 30, 2026. For fiscal 2025 it was $10.79M, up 940.4% from the year before. Over ten years it grew -2.5% a year on average. The highest annual figure on record is $13.89M in fiscal 2014.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $10.79M | +940.4% |
| FY2024 | Sep 30, 2024 | $1.04M | -80.7% |
| FY2023 | Sep 30, 2023 | $5.36M | -24.4% |
| FY2022 | Sep 30, 2022 | $7.09M | -9.5% |
| FY2021 | Sep 30, 2021 | $7.84M | +8.7% |
| FY2020 | Sep 30, 2020 | $7.21M | +43.4% |
| FY2019 | Sep 30, 2019 | $5.03M | -48.7% |
| FY2018 | Sep 30, 2018 | $9.81M | +49.4% |
| FY2017 | Sep 30, 2017 | $6.57M | -42.4% |
| FY2016 | Sep 30, 2016 | $11.41M | -17.9% |
| FY2014 | Aug 31, 2014 | $13.89M | +76.7% |
| FY2013 | Aug 31, 2013 | $7.86M | +686.8% |
| FY2012 | Aug 31, 2012 | $999.00K | -75.9% |
| FY2011 | Aug 31, 2011 | $4.15M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $10.30M | -16.9% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $10.00M | -28.1% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $12.10M | +656.3% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $10.79M | +940.4% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $12.40M | +507.6% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $13.90M | +396.5% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $1.60M | -62.5% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $1.04M | -80.7% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $2.04M | -68.4% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $2.80M | -62.5% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $4.27M | -48.4% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $5.36M | -24.4% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $6.46M | -49.6% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $7.47M | -53.0% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $8.27M | +40.6% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $7.09M | -9.5% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $12.81M | +59.1% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $15.89M | +44.9% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $5.88M | -6.7% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $7.84M | +8.7% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $8.05M | +42.8% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $10.97M | +56.9% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $6.31M | +45.7% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $7.21M | +43.4% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $5.64M | -11.4% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $6.99M | +129.8% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $4.33M | -12.9% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $5.03M | -48.7% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $6.36M | -32.3% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $3.04M | -19.8% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $4.97M | -17.2% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $9.81M | +49.4% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $9.40M | +23.0% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $3.79M | -55.9% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $6.00M | -39.3% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $6.57M | -42.4% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $7.65M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $8.60M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $9.88M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $11.41M | – |
See a number that looks wrong?